Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections

Phase: N/A Priority: Normal
NCT ID: NCT01066507 Org: User:
Start: 07/31/08 End: 01/31/10 Due: 01/31/11

Identification and Semi-Quantification of Ki-67 Protein Expression Status

Phase: N/A Priority: Normal
NCT ID: NCT02654457 Org: User:
Start: 12/31/13 End: 01/31/15 Due: 01/31/16

Immunohistochemical (IHC) Scoring for Receptors Expression in Breast Tissues

Phase: N/A Priority: Normal
NCT ID: NCT00978276 Org: User:
Start: 05/31/06 End: - Due: -

Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue

Phase: N/A Priority: Normal
NCT ID: NCT02654444 Org: User:
Start: 05/31/13 End: 01/31/15 Due: 01/31/16

Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)

Phase: N/A Priority: Normal
NCT ID: NCT01620853 Org: User:
Start: 05/31/12 End: 01/31/13 Due: 01/31/14

Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

Phase: N/A Priority: Normal
NCT ID: NCT01264744 Org: User:
Start: 11/30/09 End: 08/31/10 Due: 08/31/11

Identification and Semi -Quantification of ER/PR Proteins Expression

Phase: N/A Priority: Normal
NCT ID: NCT02654431 Org: User:
Start: 05/31/13 End: 12/31/14 Due: 12/31/15